These results suggest that E2F1 may be an upstream regulator of MIR20B in the liver, and this upregulation of MIR20B regulates lipid metabolism in the pathogenesis of NAFLD. The gene discussed is MIR20B; the disease is metabolic dysfunction-associated steatotic liver disease.